Literature DB >> 25098691

Subclinical atherosclerosis in systemic lupus erythematosus patients and its relationship to disease activity and damage indices.

S Fadda1, H Nassar, S M Gamal, H Al-azizi.   

Abstract

AIM OF THE WORK: To detect the incidence of premature atherosclerosis in systemic lupus erythematosus (SLE) patients and to study its association with disease activity and damage indices. PATIENTS AND METHODS: This study involved 50 adult female SLE patients with mean age 26.24 ± 8.63 years and mean disease duration 3.44 ± 4.01 years. The control group comprised 25 healthy adult females. All patients were subjected to a detailed clinical examination and laboratory investigations, and full case history was recorded. Assessment of disease activity was performed according to the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) and disease damage was assessed using the Systemic Lupus International Collaborating Clinics (SLICC) score. B mode ultrasound was used to measure the intima-media wall thickness (IMT) and detect the presence of carotid plaques.
RESULTS: In 15 patients (30 %), positive ultrasonographic findings represented by a significant increase in IMT (> 0.9 mm) could be shown; plaques were found in 3 of these patients (6 %). A significant difference was found between SLE patients and controls in terms of IMT (P < 0.0001). On subgrouping the SLE patients according to their IMT, there was a significant difference between those with thickened and normal IMT in terms of SLEDAI (P < 0.0001) and SLICC (p = 0.035) scores.
CONCLUSION: Subclinical atherosclerosis is frequent in SLE patients. Increased disease activity and damage are associated with the occurrence of premature atherosclerosis.

Entities:  

Mesh:

Year:  2015        PMID: 25098691     DOI: 10.1007/s00393-014-1473-1

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  30 in total

1.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

2.  The impact of obesity in systemic lupus erythematosus on disease parameters, quality of life, functional capacity and the risk of atherosclerosis.

Authors:  Amal Rizk; Tamer A Gheita; Sahar Nassef; Abeer Abdallah
Journal:  Int J Rheum Dis       Date:  2012-06       Impact factor: 2.454

3.  Lupus Atherosclerosis Prevention Study (LAPS).

Authors:  M A Petri; A N Kiani; W Post; L Christopher-Stine; L S Magder
Journal:  Ann Rheum Dis       Date:  2010-12-21       Impact factor: 19.103

4.  Cardiovascular risk stratification in rheumatic diseases: carotid ultrasound is more sensitive than Coronary Artery Calcification Score to detect subclinical atherosclerosis in patients with rheumatoid arthritis.

Authors:  Alfonso Corrales; José A Parra; Carlos González-Juanatey; Javier Rueda-Gotor; Ricardo Blanco; Javier Llorca; Miguel A González-Gay
Journal:  Ann Rheum Dis       Date:  2013-07-13       Impact factor: 19.103

5.  Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus.

Authors:  Mary J Roman; Beth-Ann Shanker; Adrienne Davis; Michael D Lockshin; Lisa Sammaritano; Ronit Simantov; Mary K Crow; Joseph E Schwartz; Stephen A Paget; Richard B Devereux; Jane E Salmon
Journal:  N Engl J Med       Date:  2003-12-18       Impact factor: 91.245

Review 6.  The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus.

Authors:  D Gladman; E Ginzler; C Goldsmith; P Fortin; M Liang; M Urowitz; P Bacon; S Bombardieri; J Hanly; E Hay; D Isenberg; J Jones; K Kalunian; P Maddison; O Nived; M Petri; M Richter; J Sanchez-Guerrero; M Snaith; G Sturfelt; D Symmons; A Zoma
Journal:  Arthritis Rheum       Date:  1996-03

7.  Myocardial perfusion scintigraphy and coronary disease risk factors in systemic lupus erythematosus.

Authors:  E M C Sella; E I Sato; W A Leite; J A Oliveira Filho; A Barbieri
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

8.  Cardiometabolic and immune factors associated with increased common carotid artery intima-media thickness and cardiovascular disease in patients with systemic lupus erythematosus.

Authors:  E Ammirati; E P Bozzolo; R Contri; A Baragetti; A G Palini; D Cianflone; M Banfi; P Uboldi; G Bottoni; I Scotti; A Pirillo; L Grigore; K Garlaschelli; C Monaco; A L Catapano; M G Sabbadini; A A Manfredi; G D Norata
Journal:  Nutr Metab Cardiovasc Dis       Date:  2014-02-01       Impact factor: 4.222

Review 9.  The interplay of inflammation and cardiovascular disease in systemic lupus erythematosus.

Authors:  J Michelle Kahlenberg; Mariana J Kaplan
Journal:  Arthritis Res Ther       Date:  2011-02-28       Impact factor: 5.156

10.  Increased arterial stiffness in systemic lupus erythematosus (SLE) patients at low risk for cardiovascular disease: a cross-sectional controlled study.

Authors:  Karim Sacre; Brigitte Escoubet; Blandine Pasquet; Marie-Paule Chauveheid; Maria-Christina Zennaro; Florence Tubach; Thomas Papo
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

View more
  2 in total

1.  Subclinical parameters of arterial stiffness and arteriosclerosis correlate with QRISK3 in systemic lupus erythematosus.

Authors:  Mónica Vázquez-Del Mercado; Felipe de J Perez-Vazquez; Eduardo Gomez-Bañuelos; Efrain Chavarria-Avila; Arcelia Llamas-García; Karla I Arrona-Rios; Gustavo Ignacio Diaz-Rubio; Sergio Durán-Barragán; Rosa E Navarro-Hernández; Bethel P Jordán-Estrada; Natalia Prado-Bachega; Miguel A A Gonzalez-Beltran; Carlos Ramos-Becerra; Fernando Grover-Paez; David Cardona-Müller; Ernesto G Cardona-Muñoz
Journal:  PLoS One       Date:  2018-12-05       Impact factor: 3.240

2.  Risk factors for progression of carotid intima-media thickness in patients with systemic lupus erythematosus: protocol for an observational cohort study in China.

Authors:  Haiyu Pang; Yicong Ye; Faming Ding; Mengtao Li; Xinglin Yang; Xufei Yang; Qian Wang; Dong Xu; Yunyun Fei; Lin Kang; Xiaofeng Zeng; Shuyang Zhang
Journal:  BMJ Open       Date:  2019-09-08       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.